Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
CMXC CELL MEDX CORP
0.0290.0000.00%
Trading Session
01/31 09:30 ET
High
0.000
Open
0.000
Turnover
0.00
Low
0.000
Pre Close
0.029
Volume
0.00
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Cell MedX Corp: Letter to Shareholders from Mr. Dwayne Yaretz, CEO
Carson City, Nevada--(Newsfile Corp. - June 27, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of
Cell MedX names new CEO
Cell MedX (OTCQB:CMXC) named Dwayne Yaretz as its new CEO, to succeed McEnulty, on Wednesday.The biotech company told Yaretz has held leadership roles in private and public companies."I am excited to
Cell MedX Corp. Appoints Mr. Dwayne Yaretz as CEO and Director
Carson City, Nevada--(Newsfile Corp. - April 27, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization of
No More
Company Overview
More
Cell MedX Corp. is a biotech company, which engages in the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness. Its products include microcurrent therapy and eBalance systems. The company was founded on March 19, 2010 and is headquartered in Carson City, NV.
CEO： --
Market： Pink Market
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet